Trimel to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference
16 Giugno 2014 - 9:20PM
Marketwired
Trimel to Present at the 2014 Bloom Burton & Co. Healthcare
Investor Conference
TORONTO, ONTARIO--(Marketwired - Jun 16, 2014) - Trimel
Pharmaceuticals Corporation (TSX:TRL) today announced that
management is scheduled to present an overview of the Company at
the 2014 Bloom Burton & Co. Healthcare Investor Conference at
the Toronto Board of Trade on June 18th, 2014 at 2:30 p.m. (Eastern
time). The presentation materials will also be made available on
the Trimel website at www.trimelpharmaceuticals.com.
About Trimel
Trimel is a specialty pharmaceutical company actively developing
medications for male hypogonadism, female sexual dysfunction and
various respiratory disorders. Natesto™, a product utilizing
Trimel's licensed bioadhesive nasal gel technology, has been
approved for sale in the United States by the FDA. For more
information, please visit www.trimelpharmaceuticals.com.
Trimel Pharmaceuticals CorporationKenneth HowlingChief Financial
Officer(416)
679-0536ir@trimelpharmaceuticals.comwww.trimelpharmaceuticals.com
Grafico Azioni Trilogy International Pa... (TSX:TRL)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Trilogy International Pa... (TSX:TRL)
Storico
Da Mag 2023 a Mag 2024
Notizie in Tempo Reale relative a Trilogy International Partners Inc (Borsa di Toronto (TSX)): 0 articoli recenti
Più Trimel Pharmaceuticals Corp Articoli Notizie